![](/img/cover-not-exists.png)
A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma
Corso, A, Varettoni, M, Zappasodi, P, Klersy, C, Mangiacavalli, S, Pica, G, Lazzarino, MVolume:
21
Year:
2007
Language:
english
Pages:
4
DOI:
10.1038/sj.leu.2404682
File:
PDF, 97 KB
english, 2007